MeSH tree: D12.776.964
Over half of the people carrying HIV experience chronic pain at some point, which is difficult to treat. In a new JNeurosci paper, Hui-Lin Pan, from The University of Texas MD Anderson Cancer Center, and colleagues used mice ...
Jun 1, 2026
0
6
People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked. FIU researchers have now uncovered a previously unknown mechanism that helps explain how HIV causes ...
Apr 25, 2026
0
7
An international team of researchers has identified an East African bat coronavirus capable of entering human cells. While the virus—Cardioderma cor coronavirus (CcCoV) KY43, or CcCoV-KY43—can bind to a cell receptor found ...
Apr 22, 2026
0
9
For decades, scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years of probing work and extensive experimentation, a Yale research team has unlocked one of the reasons ...
Mar 13, 2026
0
13
Researchers from Monash University and the Lions Eye Institute have discovered a tissue protein that acts as a central 'traffic controller' for immune cells and can be hijacked by a virus to weaken immune responses.
Jan 25, 2026
0
50
United States President Donald Trump this week claimed children should not be vaccinated against hepatitis B until they are 12 years old, rather than at birth. He also said the viral liver infection was a sexually transmitted ...
Sep 25, 2025
0
14
Researchers from National Taiwan University Hospital and Academia Sinica have identified a simple blood marker that can reliably pinpoint chronic hepatitis B (CHB) patients at negligible risk of developing liver cancer.
Sep 12, 2025
0
26
Liver specialist Maurizio Bonacini is in the race for a cure for hepatitis B, one of the world's most widespread diseases and a top cause of liver cancer around the globe.
Sep 3, 2025
0
12
Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and resurfacing even after treatment. But, thanks to a new class of drugs, its luck may be running out.
Jul 23, 2025
0
73
A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney has shown strong potential to protect against both current and emerging coronavirus variants. By ...
Jul 18, 2025
0
420
